CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:Nuoyu Medical

China's First Homegrown Radiopharmaceutical Receives Dual FDA Breakthrough Therapy and Fast Track Designations

China's First Homegrown Radiopharmaceutical Receives Dual FDA Breakthrough Therapy and Fast Track Designations

On August 6, Nuoyu Medical announced that the U.S. Food and Drug Administration (FDA) has officially granted Breakthrough Therapy Designation (BTD) and Fast Track Designation (FTD) to the company's independently developed 68Ga-NYM096. This marks the first product in China's original radiopharmaceutical field to receive FDA Breakthrough Therapy Designation, and the first to receive both FDA Breakthrough Therapy and Fast Track designations simultaneously, creating a milestone breakthrough in the radiopharmaceutical field. 68Ga-NYM096 is a small-molecule diagnostic radiopharmaceutical for renal cancer that specifically binds to CAIX, suitable for positron emission tomography (PET) imaging of suspected or confirmed metastatic clear cell renal cell carcinoma (c...

2026-08-08

Reading Ranking

  • 1 South China Regional Office carries out supervision of core equipment at Changjiang Small Modular Reactor
  • 2 China's First Actinium-225 Mass Production Qualification Lands in Chongqing: SPIC Isotope Synergy Accelerates Breakthrough in High-End Medical Isotope Supply Chain Bottleneck
  • 3 U.S. NRC Accepts Construction Application for Blue Energy Project
  • 4 Southwest Regional Office of the Ministry of Ecology and Environment Visits CNNC Sichuan Environmental Protection for Exchange
  • 5 Iranian Atomic Energy Organization Official Says Domestically Built Fusion Device Will Be Commissioned
  • 6 Breakthrough in New Bacterial Imaging Agent Developed by UCSF
  • 7 Zhongke Qingneng Wins Bid for DongSheng Fusion HOPE Device Cryogenic System
  • 8 Topological Fusion of Magnetic Mirror and Stellarator: How Fu Guoyong's Team's "Linked-Mirror" Deduces a New Engineering Pathway for Controlled Nuclear Fusion
  • 9 Oklo Partners with U.S. Forged Rings to Reshape Domestic Nuclear Manufacturing
  • 10 Singapore Enhances Nuclear Energy Assessment Capabilities Ahead of International Review
  • 11 New York Power Authority Announces Shortlisted Developers for Nuclear Energy Project
  • 12 Russia's Bureau 1440 tests satellite communications on nuclear icebreaker
  • 13 France Releases Ten-Year Nuclear Fusion Energy Development Strategy Roadmap
  • 14 France's Newcleo Partners with US Curio to Advance Nuclear Fuel Recycling
  • 15 Saint Vincent and the Grenadines Hosts Nuclear Safeguards Workshop
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9